# Clinical Impact of Orsiro™ Stent in Patient With Chronic Kidney Disease

Study · id `cardio:ct-nct06475625` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06475625](<https://clinicaltrials.gov/study/NCT06475625>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06475625

Browse, organ or system: Heart; Kidneys  
Browse, condition area: Coronary and vascular disease; Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 3113 participants.

## Technical summary

Registry record NCT06475625. Non-randomized; no masking; primary purpose treatment. Start 2019-10-22 (actual); primary completion 2025-01-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 3113 participants (enrolled count; ClinicalTrials.gov record NCT06475625, source copy `cardio:ctgov-nct06475625-2024-06-26`, retrieved 2026-10-26)
- Started: 2019-10-22 (actual) (ClinicalTrials.gov record NCT06475625, source copy `cardio:ctgov-nct06475625-2024-06-26`, retrieved 2026-10-26)
- Primary completion: 2025-01-01 (anticipated) (ClinicalTrials.gov record NCT06475625, source copy `cardio:ctgov-nct06475625-2024-06-26`, retrieved 2026-10-26)
- Completion: 2027-01-01 (anticipated) (ClinicalTrials.gov record NCT06475625, source copy `cardio:ctgov-nct06475625-2024-06-26`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT06475625, source copy `cardio:ctgov-nct06475625-2024-06-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06475625-2024-06-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Impact of Orsiro™ Stent in Patient With Chronic Kidney Disease
- Acronym: OKAY
- Condition: Chronic Kidney Diseases
- Condition: Coronary Artery Disease
- Intervention (Procedure): Percutaneous coronary intervention
- Intervention (Device): Orsiro™ or Orsiro\_Mission™ stent
- Lead sponsor: The Catholic University of Korea
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: The Catholic University of Korea (`cardio:org-the-catholic-university-of-korea`)

## Provenance

Content hash: a2b5a82a75ed689058602d9e49d2cddb2291c91cf388987970e33dbc9ac1a2fe
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
